Health · 6 views
Psilocybin may improve a difficult-to-treat symptom of depression, study finds
New research from the University of Colorado Anschutz suggests that psilocybin may help improve anhedonia, the loss of interest or ability to experience pleasure, in people with treatment-resistant depression.
AI Summary
A clinical trial at the University of Colorado Anschutz found that psilocybin treatment improved anhedonia, the loss of interest or pleasure, in patients with treatment‑resistant depression. Researchers measured significant improvement in this symptom eight weeks after the psilocybin session. Anhedonia is noted as one of the most difficult depression symptoms to treat, affecting enjoyment of daily activities, social connection, and a sense of meaning even when other symptoms improve. The study suggests psilocybin could play a role in future depression care.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow